Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: episodic (5), intermittent (36), sporadic (4)

Capecitabine (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE (14 day) Regimen • Colorectal Cancer – Capecitabine (14 day) Indication • Metastatic / advanced colorectal cancer • Adjuvant therapy of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine14day.pdf

Capecitabine-TrastuzumabIV-Tucatinib

Description: Chemotherapy Protocol BREAST CANCER Capecitabine–Trastuzumab (IV)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (IV)-T
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-IV-Tucatinib.pdf

Capecitabine-Trastuzumab-SC-Tucatinib

Description: Chemotherapy Protocol BREAST CANCER Capecitabine– Trastuzumab (SC)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (SC)-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-SC-Tucatinib.pdf

Isatuximab VRD weekly

Description: Chemotherapy Protocol Myeloma Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20) Regimen Myeloma – Isa-VRD weekly Isatuximab-L
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Isatuximab-VRD-weekly-Ver1.pdf

Crizotinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CRIZOTINIB This protocol may require funding Regimen NSCLC - Crizotinib Indication The treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CrizotinibVer1.pdf

Afatinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Regimen AFATINIB NSCLC - Afatinib Indication Treatment of locally advanced or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AfatinibVer1.pdf

Vemurafenib Ver 1

Description: Chemotherapy Protocol SKIN CANCER Regimen VEMURAFENIB Skin – Vemurafenib Indication Vemurafenib is recommended as an option for the treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinVemurafenibVer1.pdf

Capecitabine-Epirubicin-Oxaliplatin (EOX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, EPIRUBICIN and OXALIPLATIN (EOX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Epirubicin-Oxaliplatin (EOX) Indication • First line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Epirubicin-Oxaliplatin.pdf

Capecitabine-Cisplatin-Epirubicin (ECX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, CISPLATIN and EPIRUBICIN (ECX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Cisplatin-Epirubicin (ECX) Indication • First line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Epirubicin.pdf

Capecitabine-Oxaliplatin 4-cycles

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and OXALIPLATIN (CAPOX-4 cycles) Regimen • Colorectal Cancer – Capecitabine-Oxaliplatin 4 cycles (CAPOX-4 cycles) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Oxaliplatin-4-cycles.pdf

31 to 40 of 187

Previous … 2 3 4 5 6 … Next